Evonik begins construction of second methionine plant in Singapore

German specialty chemicals company, Evonik Industries, plans to build a second world-scale plant for the production of the amino acid DL-methionine in Singapore are fully on schedule. The complex will have an annual production capacity of 150,000 metric tonnes (MT) and is expected to become operational in 2019, with investment costs of more than half a billion euros. Evonik sells DL-methionine under the brand name MetAMINO.

The success of its first methionine complex, which came on-stream in late 2014 on Jurong Island has prompted the company to build a second plant next to it, according to Klaus Engel, the chairman of the Executive Board of Evonik Industries. “The demand for MetAMINO for animal nutrition is continuing to grow at a very fast rate in Asia." The new plant will not only produce methionine, but also all strategically important precursors to guarantee product quality and supply security. “Singapore has proven an ideal location for supplying our Asian customers,” said Reiner Beste, chairman of the Board of Management of Evonik Nutrition & Care GmbH. The new complex will create more than 150 jobs at the location.

The new production complex will increase Evonik’s annual capacity of MetAMINO to a total of approximately 300,000 MT in Asia, and to approximately 730,000 metric tons worldwide. The specialty chemicals company produces the amino acid in its world-scale plants in Antwerp (Belgium), Wesseling/Cologne (Germany), Mobile (Alabama, USA), and Singapore.

DL-methionine is an essential amino acid, which must be absorbed through feed intake. As a feed additive, it contributes to the efficient, healthy and environmentally friendly nutrition of livestock, particularly poultry and swine. That makes it an important component of ensuring a sustainable animal protein supply for the world’s growing population.